Company: LIMN
Filing Date: 2025-01-16
Form Type: POS AM
Source: 0001104659-25-003835
Chunk: 682

Company: Liminatus Pharma, Inc.
Filing Date: 2025-01-16
Form: POS AM
Chunk 682
---
 26, 2024, by and among Iris Acquisition Corp, a Delaware corporation (the “

#### SPAC
”), Iris Parent Holding Corp., a Delaware corporation (“

#### ParentCo
”), and Liminatus Pharma, LLC, a Delaware limited liability company (the “

#### Company
”). Each of SPAC, ParentCo, and the Company is also referred to herein as a “

#### Party
” and, collectively, the “

#### Parties
”.

### RECITALS
WHEREAS, the Parties, along with Liminatus Pharma Merger Sub, Inc., a Delaware corporation, and SPAC Merger Sub, Inc., a Delaware corporation, entered into that certain Business Combination Agreement, dated November 30, 2022 (the “

#### BCA
”);

WHEREAS, the Parties previously entered into that certain Amendment to Business Combination Agreement, dated June 1, 2023, to, among other things, extend the Outside Date (as defined in the BCA) to September 11, 2023;

WHEREAS, the Parties previously entered into that certain Second Amendment to Business Combination Agreement, dated August 14, 2023, to among other things, extend the Outside Date (as defined in the BCA) to March 9, 2024;

WHEREAS, the Parties previously entered into that certain Third Amendment to Business Combination Agreement, dated March 9, 2024, to among other things, extend the Outside Date (as defined in the BCA) to July 31, 2024;

WHEREAS, the Parties previously entered into that certain Fourth Amendment to Business Combination Agreement, dated July 19, 2024, to among other things, extend the Outside Date (as defined in the BCA) to September 3, 2024;

WHEREAS, the Parties previously entered into that certain Fifth Amendment to Business Combination Agreement, dated August 16, 2024, to among other things, extend the Outside Date (as defined in the BCA) to December 31, 2024;

WHEREAS, the Parties previously entered into that certain Sixth Amendment to Business Combination Agreement, dated October 23, 2024, to among other things, reduce the Company Merger Consideration, amend the Cap, and reduce the number of Merger Shares (each as defined in the BCA);

WHEREAS, the Parties desire to further amend the BCA to, among other things, extend the Outside Date (as defined in the BCA